The Prospective Observational Study for Realistically Concomitant Use of Corticosteroid in Idiopathic Pulmonary Fibrosis during Treatment with Anti-fibrotic Agents
- Conditions
- Idiopathic pulmonary fibrosis
- Registration Number
- JPRN-UMIN000038148
- Lead Sponsor
- Department of Respiratory Medicine, Juntendo University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Not provided
(1) Severe heart disease (2) AST >=1.5*ULN or ALT >=1.5*ULN, (3) T-bil >=1.5*ULN (4) Cr >=1.5*ULN (5) A patient who had ever received anti-cancer agents or radiation therapy (6) Pregnancy (7) A patient who can not receive pulmonary function test (8) A patient who already receive immunosuppressant, including azatiopurinn, cyclosporine, cyclophosphamide, methotrexate, tacrolimus) (9) Coexistence with pulmonary arterial hypertension, bronchial asthma, Malignant tumor, sarcoidosis, bronchiectasis, respiratory infection (10) A patient with risk of fatal bleeding (11) Past history of thrombosis (12) Having HBV antigen and HVB-DNA (13) A patient who started clinical trials less than 3 months (14) A patient improper to this clinical trial according to the decision of a principal investigator
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method